Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats
Open Access
- 14 November 2008
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 16 (4) , 362-372
- https://doi.org/10.1038/cgt.2008.80
Abstract
Conditionally replicative adenoviruses (CRAds) are often evaluated in mice; however, normal and cancerous mouse tissues are poorly permissive for human CRAds. As the cotton rat (CR) is a semipermissive animal and the Syrian hamster (SH) is a fully permissive model for adenoviral replication, we compared them in a single study following intracranial (i.c.) injection of a novel glioma-targeting CRAd. Viral genomic copies were quantified by real-time PCR in brain, blood, liver and lung. The studies were corroborated by immunohistochemical, serological and immunological assays. CR had a multiple log higher susceptibility for adenoviral infection than SH. A similar amount of genomic copies of CRAd-Survivin-pk7 and human adenovirus serotype 5 (AdWT) was found in the brain of CR and in all organs from SH. In blood and lung of CR, AdWT had more genomic copies than CRAd-Survivin-pk7 in some of the time points studied. Viral antigens were confirmed in brain slices, an elevation of serum transaminases was observed in both models, and an increase in anti-adenoviral antibodies was detected in SH sera. In conclusion, CR represents a sensitive model for studying biodistribution of CRAds after i.c. delivery, allowing for the detection of differences in the replication of CRAd-Survivin-pk7 and AdWT that were not evident in SH.Keywords
This publication has 39 references indexed in Scilit:
- Low-Dose Radiation Enhances Survivin-Mediated Virotherapy against Malignant Glioma Stem CellsCancer Research, 2008
- A Capsid-Modified, Conditionally Replicating Oncolytic Adenovirus Vector Expressing TRAIL Leads to Enhanced Cancer Cell Killing in Human Glioblastoma ModelsCancer Research, 2007
- Survivin-Driven and Fiber-Modified Oncolytic Adenovirus Exhibits Potent Antitumor Activity in Established Intracranial GliomaHuman Gene Therapy, 2007
- Fiber‐knob modifications enhance adenoviral tropism and gene transfer in malignant gliomaThe Journal of Gene Medicine, 2007
- Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirusMolecular Cancer Therapeutics, 2006
- The human survivin promoter: a novel transcriptional targeting strategy for treatment of gliomaJournal of Neurosurgery, 2006
- Oncolytic adenoviral therapy for glioblastoma multiformeNeurosurgical Focus, 2006
- Cotton Rat Tumor Model for the Evaluation of Oncolytic AdenovirusesHuman Gene Therapy, 2005
- Gene Therapy on TrialScience, 2000
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977